Case Report: COVID-19 Vaccination Associated Fulminant Myocarditis.
Front Cardiovasc Med
; 8: 769616, 2021.
Article
in English
| MEDLINE | ID: covidwho-1686458
ABSTRACT
Herein, we describe a novel finding of fulminant myocarditis (FM) in two subjects the day after administration of the first dose of the currently available inactivated SARS-CoV-2 vaccine (Vero cell). Cardiac magnetic resonance imaging revealed extensive myocardial edema and necrosis. A pathologic evaluation of the endocardial biopsy tissues revealed inflammatory cell (lymphocytes) infiltration and interstitial edema, myocyte necrosis, and focal areas of fibrosis. A life-support-based comprehensive treatment regimen comprising mechanical circulatory support using intra-aortic balloon pulsation and immunomodulatory therapy-glucocorticoids and intravenous immunoglobulin-was used to treat the patients with FM; eventually, the patients recovered and were discharged. To our knowledge, these are the first two reported cases of FM, with no other identified cause or associated illness, after receiving the inactivated SARS-CoV-2 vaccine (Vero cell). These findings suggest a novel pathogenesis of myocarditis which mentions to pay more attention to this rare, but lethal complication of COVID-19 vaccination.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Experimental Studies
Topics:
Vaccines
Language:
English
Journal:
Front Cardiovasc Med
Year:
2021
Document Type:
Article
Affiliation country:
Fcvm.2021.769616
Similar
MEDLINE
...
LILACS
LIS